Financial Performance Highlights - IFS's quarterly net profit in 2Q25 reached S/ 579.6 million, a 29.9% increase QoQ [207] - IFS achieved a ROE of 20.7% in 2Q25 [34] - Banking sector ROE was 11.1% in 2Q25 [35] - Wealth Management saw a significant ROE increase to 43.9% in 2Q25, approximately 20x YoY [35] - Insurance sector ROE was 58.3% in 2Q25 [35] Business Trends and Growth - System loan book as of June 2025 showed a QoQ increase of 3.1% and a YoY increase of 1.7% [31] - Total commercial loans increased by 4.1% QoQ and 9.8% YoY [202] - Total retail loans increased by 1.1% QoQ and 1.2% YoY [202] - Total deposits increased by 2.7% QoQ and 7.4% YoY, reaching S/ 52,036.0 million [204] Key Ratios and Indicators - IFS's cost-to-income (C/I) ratio was 35.9% in 2Q25 [45] - Banking sector's C/I ratio was 42.3% in 2Q25 [49] - Banking sector's NIM was 5.1% [136] - The cost of risk for the banking sector is at 2.5% [139]

August 12, 2025 Corporate Relationship Department Exchange Plaza 1st Floor, New Trading Ring, Bandra Kurla Complex Rotunda Building, P. J. Towers, Bandra (E) Dalal Street, Fort, Mumbai 400 051 Mumbai – 400 001. Scrip Code: INDHOTEL Scrip Code: 500850 BSE Limited National Stock Exchange of India Limited Sub: Investor / Analyst Presentation Dear Sir, This has reference to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (the 'Re ...

NASDAQ: WPRT, TSX: WPRT August 11, 2025 Q2 2025 Results Driving Cleaner Performance Westport Fuel Systems Disclaimer and Forward-Looking Statements This presentation contains forward-looking statements, including statements regarding, future revenue expectations, future growth in markets, future of our development programs (including those relating to HPDI and Hydrogen), the global demand for our HPDI joint venture's products, the future success of our business and technology strategies, the future role of ...

Company Overview - BKV is the largest natural gas producer in the Barnett Shale, with a corporate 1-year decline rate of 10.8%[10] - BKV has 1,500 MW of low heat rate power assets in Texas[10] - BKV's 2Q25 production was above high end of guidance at 811 MMcfe/d[34] Bedrock Acquisition - BKV announced the Bedrock acquisition for $370 million, targeting close in 4Q25[22, 29] - The Bedrock acquisition includes ~97,000 net acres and 1,121 gross operated wells[29] - Bedrock's 2Q25 production is ~108 MMcfe/d (~63% natural gas) with a low PDP decline of ~7% YOY[29] - Bedrock has nearly 1 Tcfe of 1P reserves (>70% PDP reserves)[29] Capital Expenditure and Production - Forecasted 2025 capital expenditures are between $290 million and $350 million[17] - BKV is targeting projects to reach a 1 Mtpy CO2 sequestration rate by 2027[17] CCUS Business - BKV's Barnett Zero project has been injecting since November 2023, with forecasted annual sequestration of 183 ktpy[105, 106] - BKV has injected ~242,000 tons through 6/30/25 at Barnett Zero[106]

Company Overview - Bitcoin Depot is a leading BTM operator, simplifying cash-to-crypto conversion[20] - The company has installed 9,000 kiosks across North America and Australia[21] - Total transacted volume since inception is $32 billion, with 39 million transactions completed[21] - Q2 2025 Adjusted EBITDA reached $185 million[21] - TTM Q2 2025 Revenue is $608 million and Adjusted EBITDA is $61 million[21] Market Position and Growth - Bitcoin Depot holds a significant BTM market share in North America[21] - The company operates in 48 US states, DC, 10 Canadian provinces, and 6 Australian provinces[21,58] - The company's kiosks address over 64% of the US population[58] - The global Bitcoin ATM market has grown significantly, reaching 38,738 BTMs in 2025[48] Strategic Partnerships - Bitcoin Depot is Circle K's exclusive BTM provider, with over 900 kiosks deployed across the US and Canada as of March 2025[61,65] - The company partners with major retailers, expanding customer reach with limited capital expenditure[61,78]

Cautionary disclaimers Growing, multi-asset producer Camino Rojo, May 2025 FORWARD LOOKING STATEMENTS ARE MADE IN THIS PRESENTATION Q2 SECOND QUARTER 2025 UPDATE This presentation contains forward-looking statements and information within the meaning of Canadian securities law and United States securities laws, rules and legislation, including the provisions for "safe harbor" under the United States Private Securities Litigation Reform Act of 1995 (collectively, "forward-looking statements"). All statements ...

Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect Carvana's current expectations and projections with respect to, among other things, our financial condition, results of operations, plans, objectives, future performance, and business. These statements may be preceded by, followed by or include the words "aim," "anticipate," "believe," "estimate," "expect," "fore ...

Financial Performance - The company's net loss for the third quarter of fiscal 2025 was $17 million, improved from a net loss of $43.6 million in the third quarter of fiscal 2024[10] - Total company adjusted EBITDA for the third quarter of fiscal 2025 was $41 million, a 25% increase from $32.8 million in the prior year[10] - Net total debt decreased by 13% year over year and 2% sequentially to $746 million, with liquidity of $389 million as of June 30, 2025[10] - Consolidated revenue increased by 6% year-over-year[17] - Consolidated adjusted EBITDA margin was 19.1%[17] Salt Segment - Salt sales volumes increased by 4% year over year[10] - Salt segment revenue was $166 million, up 3.4% from $160.6 million in 3Q24[21] - Salt segment adjusted EBITDA was $45.8 million, up 10.1% from $41.6 million in 3Q24[21] - Salt adjusted EBITDA margin was 27.6%, an increase of 1.7 percentage points from 25.9% in 3Q24[21] Plant Nutrition Segment - Plant Nutrition sales volumes increased by 21% year over year, reaching 68 thousand short tons[10, 29] - Plant Nutrition revenue was $44.8 million, up 15.5% from $38.8 million in 3Q24[29] - Plant Nutrition adjusted EBITDA increased to $11.4 million from $7.2 million[29, 31] - Plant Nutrition adjusted EBITDA margin was 25.4%, an increase of 6.9 percentage points from 18.6% in 3Q24[29]

1st HALF OF 2025 AGEN A FINAL REMARKS 01 BUSINESS ENVIRONMENT 03 LIQUIDITY MANAGEMENT 04 DIVIDENDS 02 1H25 EARNINGS 05 06 Q&A SESSION 01 BUSINESS ENVIRONMENT MACROECONOMIC SCENARIO 01 2024 2025e² Brazilian GDP¹ 3.4% (▲ 0.2 p.p. vs. 2023) Selic¹ 12.25% p.y. (▲0.5 p.p. vs. 2023) 2.2% 15.00% p.y. 5.2% (▲0.4 p.p. vs. 2024) (▲2.75 p.p. vs. 2024) (▼1.2 p.p. vs. 2024) 2026e² 1.5% 12.75% p.y. 4.4% (▼0.8 p.p. vs. 2025e) (▼2.25 p.p. vs. 2025e) (▼0.6 p.p. vs. 2025e) (1) IBGE. (2) Itaú BBA's projections (Jul/2025). IPC ...

Financial Performance - H1 2025 - Total revenues reached €97.6 million, representing a 38% year-over-year growth[10] - Product sales amounted to €91 million, driven by IXIARO®/JESPECT®, DUKORAL®, and IXCHIQ®[62] - IXCHIQ® sales showed significant growth, increasing by 688% to €7.5 million[62] - The company experienced a significant reduction in operating cash burn, targeting a 50% reduction compared to 2024[10] - Adjusted EBITDA was a loss of €6.0 million[64] Product Performance - H1 2025 - IXIARO®/JESPECT® sales increased by 30.6% to €54.7 million[62] - DUKORAL® sales increased by 16.4% to €17.4 million, including €1.1 million from doses supplied to Mayotte[62, 63] - Third-party product sales increased by 8.8% to €11.4 million[62] Financial Outlook - 2025 - The company projects product sales between €170 million and €180 million[70] - Total revenues are expected to be in the range of €180 million to €190 million[70] - R&D expenses are projected to be between €90 million and €100 million, partially offset by grant funding and R&D tax credits[70]